Cargando…

Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development

Paracetamol (acetaminophen) is the preferred antipyretic/analgesic for pregnant women as it is believed there are no adverse fetal effects at the recommended dose. However, emerging evidence suggests that intrauterine paracetamol exposure may be associated with certain urogenital/reproductive disord...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadokoro-Cuccaro, Rieko, Fisher, Benjamin G., Thankamony, Ajay, Ong, Ken K., Hughes, Ieuan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047911/
https://www.ncbi.nlm.nih.gov/pubmed/35499038
http://dx.doi.org/10.3389/ftox.2022.884704
_version_ 1784695827404423168
author Tadokoro-Cuccaro, Rieko
Fisher, Benjamin G.
Thankamony, Ajay
Ong, Ken K.
Hughes, Ieuan A.
author_facet Tadokoro-Cuccaro, Rieko
Fisher, Benjamin G.
Thankamony, Ajay
Ong, Ken K.
Hughes, Ieuan A.
author_sort Tadokoro-Cuccaro, Rieko
collection PubMed
description Paracetamol (acetaminophen) is the preferred antipyretic/analgesic for pregnant women as it is believed there are no adverse fetal effects at the recommended dose. However, emerging evidence suggests that intrauterine paracetamol exposure may be associated with certain urogenital/reproductive disorders in the offspring. In this mini-review, we describe human fetal sex development and possible pharmacological mechanisms by which paracetamol may disrupt this process, including reduced testicular production of testosterone and/or insulin-like peptide 3. We then review the available epidemiological literature on associations between maternal paracetamol exposure and offspring sexual development. Three epidemiological studies have reported associations between maternal paracetamol intake and increased risk of cryptorchidism, although five others have not. None have found associations with hypospadias or penile length. Two out of three studies have reported a shorter anogenital distance (a marker of androgen action during the masculinisation programming window, ∼8–14 weeks of gestation) in male infants antenatally exposed to paracetamol. One study has described a dose-dependent relationship between maternal paracetamol consumption and earlier female (but not male) attainment of puberty. Such epidemiological analyses are complicated by various factors, including method of paracetamol exposure assessment (usually retrospective self-report), variation in diagnostic accuracy, selection bias, confounding by clinical indication, and demographic/genetic differences between geographically separated populations. There is an urgent need for stronger evidence in this area, from both relevant experimental studies and large, carefully-designed prospective studies. In the meantime, a precautionary attitude to gestational paracetamol usage should be considered as the evidence for clinically significant reproductive effects in humans is limited.
format Online
Article
Text
id pubmed-9047911
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90479112022-04-29 Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development Tadokoro-Cuccaro, Rieko Fisher, Benjamin G. Thankamony, Ajay Ong, Ken K. Hughes, Ieuan A. Front Toxicol Toxicology Paracetamol (acetaminophen) is the preferred antipyretic/analgesic for pregnant women as it is believed there are no adverse fetal effects at the recommended dose. However, emerging evidence suggests that intrauterine paracetamol exposure may be associated with certain urogenital/reproductive disorders in the offspring. In this mini-review, we describe human fetal sex development and possible pharmacological mechanisms by which paracetamol may disrupt this process, including reduced testicular production of testosterone and/or insulin-like peptide 3. We then review the available epidemiological literature on associations between maternal paracetamol exposure and offspring sexual development. Three epidemiological studies have reported associations between maternal paracetamol intake and increased risk of cryptorchidism, although five others have not. None have found associations with hypospadias or penile length. Two out of three studies have reported a shorter anogenital distance (a marker of androgen action during the masculinisation programming window, ∼8–14 weeks of gestation) in male infants antenatally exposed to paracetamol. One study has described a dose-dependent relationship between maternal paracetamol consumption and earlier female (but not male) attainment of puberty. Such epidemiological analyses are complicated by various factors, including method of paracetamol exposure assessment (usually retrospective self-report), variation in diagnostic accuracy, selection bias, confounding by clinical indication, and demographic/genetic differences between geographically separated populations. There is an urgent need for stronger evidence in this area, from both relevant experimental studies and large, carefully-designed prospective studies. In the meantime, a precautionary attitude to gestational paracetamol usage should be considered as the evidence for clinically significant reproductive effects in humans is limited. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9047911/ /pubmed/35499038 http://dx.doi.org/10.3389/ftox.2022.884704 Text en Copyright © 2022 Tadokoro-Cuccaro, Fisher, Thankamony, Ong and Hughes. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Toxicology
Tadokoro-Cuccaro, Rieko
Fisher, Benjamin G.
Thankamony, Ajay
Ong, Ken K.
Hughes, Ieuan A.
Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development
title Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development
title_full Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development
title_fullStr Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development
title_full_unstemmed Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development
title_short Maternal Paracetamol Intake During Pregnancy—Impacts on Offspring Reproductive Development
title_sort maternal paracetamol intake during pregnancy—impacts on offspring reproductive development
topic Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047911/
https://www.ncbi.nlm.nih.gov/pubmed/35499038
http://dx.doi.org/10.3389/ftox.2022.884704
work_keys_str_mv AT tadokorocuccarorieko maternalparacetamolintakeduringpregnancyimpactsonoffspringreproductivedevelopment
AT fisherbenjaming maternalparacetamolintakeduringpregnancyimpactsonoffspringreproductivedevelopment
AT thankamonyajay maternalparacetamolintakeduringpregnancyimpactsonoffspringreproductivedevelopment
AT ongkenk maternalparacetamolintakeduringpregnancyimpactsonoffspringreproductivedevelopment
AT hughesieuana maternalparacetamolintakeduringpregnancyimpactsonoffspringreproductivedevelopment